Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 307576, 7 pages
http://dx.doi.org/10.1155/2015/307576
Clinical Study

Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer

1Division of Hematology and Oncology, Show Chwan Memorial Hospital, Changhua, Taiwan
2Faculty of Medicine, National Yang Ming University, Taipei, Taiwan
3Program in Molecular Medicine, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan
4Division of Hematology and Oncology, Department of Medicine, Taipei Veterans General Hospital, No. 201, Section 2, Shih-Pai Road, Taipei 112, Taiwan
5Department of Medicine, Taipei City Hospital, Yang-Ming Branch, Taipei, Taiwan
6Department of Oncology Medicine, Taipei Veterans General Hospital, Taipei, Taiwan
7Department of Otolaryngology, Taipei Veterans General Hospital, Taipei, Taiwan
8Institute of Clinical Medicine, National Yang Ming University, Taipei, Taiwan

Received 4 September 2014; Revised 13 November 2014; Accepted 14 November 2014

Academic Editor: Yun Yen

Copyright © 2015 Hsueh-Ju Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Hsueh-Ju Lu, Chao-Chun Yang, Ling-Wei Wang, et al., “Modified Weekly Cisplatin-Based Chemotherapy Is Acceptable in Postoperative Concurrent Chemoradiotherapy for Locally Advanced Head and Neck Cancer,” BioMed Research International, vol. 2015, Article ID 307576, 7 pages, 2015. https://doi.org/10.1155/2015/307576.